| |
|
| [04.26.06] |
Dr. Guizhou Hu, BioSignia, V.P. Research & Development Awarded Triangle Business Journal's Health Care Hero Award in the Category of Innovation |
| [02.01.06] |
BioSignia Part of IHPM/Abbott Initiative in China |
| [10.18.05] |
BioSignia Scientists Publish Synthesis Analysis Validation Study |
| [10.21.04] |
BioSignia’s H-CAT technology named “Best Enabling Tool for Disease Management” by DMAA |
| [08.16.02] |
BioSignia Scientist Invited to Present BioMarker Research During International Conference on Drug Development European Federation for Pharmaceutical Sciences Meets December in Basel, Switzerland |
| [07.26.02] |
Duke University Medical Center, BioSignia Team Up for Year-Long Study to Test Effectiveness of Intensive “Strategic Health Planning” in Patient Care |
| [07.02.02] |
BioSignia Scientists Present Results of Novel Predictive Modeling To Identify New Drug Targets to Prevent Heart Disease |
| [09.10.01] |
BioSignia, Inc. Partners With Duke University to Conduct Stroke Study |
| [06.21.01] |
BioSignia Presents Diabetes Management Tool at ADA Annual Meeting |
| [11.10.00] |
BioSignia® Awarded Two Patents Representing Medical Technology Milestone Unique Tools Help Physicians Predict Chronic Disease Onset, Speed Drugs to Market |
| [11.01.00] |
First-of-its-kind technology places power of evidence based medicine at the fingertips of healthcare providers & consumers |
